Gefitinib Inhibits the Growth and Invasion of Urothelial Carcinoma Cell Lines in which Akt and MAPK Activation Is Dependent on Constitutive Epidermal Growth Factor Receptor Activation-Reference-Cited by-同舟云学术

Gefitinib Inhibits the Growth and Invasion of Urothelial Carcinoma Cell Lines in which Akt and MAPK Activation Is Dependent on Constitutive Epidermal Growth Factor Receptor Activation

Published:2006-05-01 Issue:9 Volume:12 Page:2937-2943
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Nicolle Gaëlle,Daher Ahmad,Maillé Pascale,Vermey Marcel,Loric Sylvain,Bakkar Ashraf,Wallerand Hervé,Vordos Dimitrios,Vacherot Francis,de Medina Sixtina Gil Diez,Abbou Claude C.,Kwast Theodore Van der,Thiery Jean-Paul,Radvanyi François,Chopin Dominique K.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gefitinib-induced hemorrhagic cystitis and inflammatory contracted bladder in a patient with advanced lung adenocarcinoma harboring compound epidermal growth factor receptor G719S and S768I missense mutations: a case report;Annals of Translational Medicine;2022-07

2. Hemorrhagic Cystitis Associated With Gefitinib Treatment: A Case Report;Urology;2018-10

3. Three-dimensional organotypic matrices from alternative collagen sources as pre-clinical models for cell biology;Scientific Reports;2017-12

4. Targeting Hsp90 in urothelial carcinoma;Oncotarget;2015-03-26

5. Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma;European Journal of Cancer;2013-04